2004
DOI: 10.1186/cc2852
|View full text |Cite
|
Sign up to set email alerts
|

Untitled

Abstract: The LiDCO™plus system is a minimally/non-invasive technique of continuous cardiac output measurement. In common with all cardiac output monitors this technology has both strengths and weaknesses. This review discusses the technological basis of the device and its clinical application.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
17
0

Year Published

2008
2008
2020
2020

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 104 publications
(19 citation statements)
references
References 62 publications
0
17
0
Order By: Relevance
“…The LiDCOplus system (LiDCO Ltd, Cambridge, UK) is also well validated [ 57 ]. In 2005 Pearse and colleagues [ 38 ] conducted a RCT of post-operative GDT in high-risk general surgical patients using colloid and dopexamine to achieve a 2 or conventional management DO 2 I of 600 ml/minute/m using the LiDCOplus to measure CO.…”
Section: How To Perform Goal Directed Therapy In High-risk Surgical Pmentioning
confidence: 99%
“…The LiDCOplus system (LiDCO Ltd, Cambridge, UK) is also well validated [ 57 ]. In 2005 Pearse and colleagues [ 38 ] conducted a RCT of post-operative GDT in high-risk general surgical patients using colloid and dopexamine to achieve a 2 or conventional management DO 2 I of 600 ml/minute/m using the LiDCOplus to measure CO.…”
Section: How To Perform Goal Directed Therapy In High-risk Surgical Pmentioning
confidence: 99%
“…Additional methods of CO monitoring were also evaluated and suggested a lower rate of utilization. These methods included the ED,[5] NICO,[20] PiCCO,[1] LiDCO,[21] and combination of bioimpedance and bioreactance technologies. [22] The biggest disadvantages of bioimpedance devices are their sensitivity to motion and arrhythmogenic response to the use of electrocautery.…”
Section: Discussionmentioning
confidence: 99%
“…Methods based on pulse-wave analysis have become increasingly accepted and gradually introduced into clinical practice 5-10. Commercially available devices include the PiCCOsystem (PiCCO™, Pulsion Medical Systems) and the LiDCO-system (LiDCO™, LiDCO Ltd.), which both require invasive calibration by either transpulmonary thermodilution or lithium dilution after a certain time to compensate for interindividual differences in vascular compliance 19. The FloTrac/Vigileo™ system offers the possibility of uncalibrated, continuous CO measurements on the basis of arterial waveform analysis combined with simple usability.…”
Section: Discussionmentioning
confidence: 99%
“…The results of these techniques with respect to reproducibility and accuracy are not uniform 11-13,19. Whether they can guide therapy better than routine measurement of blood pressure remains to be determined.…”
Section: Discussionmentioning
confidence: 99%